We’d like to hear from people affected by this story and find out what this means for the availability of other drugsTwo ‘breakthrough’ breast cancer drugs are to be available on the NHS after the National Institute for Health and Care Excellence (kind) negotiated prices for the treatments.
The standard price for one cycle of palbociclib is £2950 for a pack of 21 capsules. The list price for one cycle of ribociclib is also £2950 but this is for 63 tablets. The company had first offered the drug at a price that was rejected by kind, but they had later advance to a “confidential agreement around the price”.
Continue reading...
Source: guardian.co.uk